Kidney cancer patients may soon have more treatment choices that provide a higher quality of life, thanks to new research. A recent study showed that treating metastatic kidney cancer with an advanced and focused form of radiation called stereotactic ablative radiation therapy achieves more than 90 percent control of local tumors, and offers the possibility of safely delaying systemic therapy.